India's TB Deaths Down 38%, Treatment Success at 94%: What the WHO Report Says — Explained
The WHO's Global Tuberculosis Report 2026 records a 38% fall in India's TB mortality since 2015 and a 94% treatment success rate. This explainer breaks down what the numbers mean, how they were reached, and what challenges remain.
India has recorded a 38 per cent reduction in tuberculosis (TB) mortality since 2015, compared with a global decline of 35 per cent, according to the World Health Organization's Global Tuberculosis Report 2026, released on 12 November 2026. The report also records a 94 per cent treatment success rate among patients with drug-susceptible TB. The Union Health Ministry said the progress reflects sustained work under the National TB Elimination Programme, including early detection, rapid diagnostics, technology-led screening and nutritional support for patients.
What the WHO report says
The headline finding of the WHO's Global Tuberculosis Report 2026 is that India's estimated TB mortality rate fell from 28 deaths per lakh population in 2015 to 18 per lakh in 2025, a reduction of 38 per cent as reported by the WHO and the Union Health Ministry. Over the same period, the global decline in TB mortality was 35 per cent, which means India's reduction has outpaced the world average by three percentage points. The report was released on 12 November 2026, and the Health Ministry issued a statement the same day highlighting the figures.
Alongside the mortality decline, the report records a treatment success rate of 94 per cent among patients with drug-susceptible TB, meaning TB that responds to standard medicines. The Health Ministry said this high success rate demonstrates the effectiveness of India's patient-centred approach, strengthened treatment delivery and sustained support for people affected by TB. The figures were described by the ministry as a significant milestone in the country's fight against tuberculosis.
The WHO's South-East Asia Regional Office also praised India's contribution to reducing TB mortality in the region, in comments reported on 13 November 2026. The acknowledgement came a day after the global report's release and underlined that India's progress matters well beyond its own borders, because the country accounts for about a quarter of all people who develop TB worldwide.
How the 38% figure was worked out
The mortality figures in the WHO report are estimates, not a simple count of death certificates. According to the Health Ministry, the WHO's assessment of India's TB mortality drew on multiple complementary sources, including the Registrar General of India's Sample Registration System (RGI/SRS), community-based verbal autopsy assessments and programme data from the Ni-kshay portal. Using several sources together is intended to strengthen the mortality estimate in a country where many TB deaths may not be recorded through a single system.
The 38 per cent figure is the headline reduction reported by the WHO and the ministry, based on the estimated mortality rate falling from 28 per lakh in 2015 to 18 per lakh in 2025. Readers should note that these rates are rounded figures as published, and the ministry's statement did not explain the detailed calculation behind the headline percentage. What is clear from the published figures is the direction and scale of the change: the estimated mortality rate fell by ten deaths per lakh people over a decade.
A further piece of evidence is still being discussed. The Indian Council of Medical Research's National Institute for Research in Tuberculosis (ICMR-NIRT) conducted a nationally representative TB prevalence survey in 2025. Its findings have been shared with the WHO and are currently under technical discussion, and the WHO is expected to publish an updated country profile for India after those discussions conclude. Until then, the 2026 report's figures remain the latest published WHO assessment.
The screening drive behind the numbers
A large part of the story is a mass screening campaign called the TB Mukt Bharat Abhiyaan. Between 7 December 2024 and 8 November 2026, more than 25 crore people were brought within the scope of screening activities under the campaign, according to the Health Ministry. In the same period, more than 11 crore chest X-rays were conducted and more than 3 crore nucleic acid amplification tests (NAAT), which are used for rapid molecular diagnosis, were carried out.
The campaign began with a first intensified 100-day screening drive launched on 7 December 2024 across 347 high-priority districts in 33 states and Union Territories, and was subsequently expanded nationwide. A second 100-day campaign was launched on 24 March 2026, focusing on 1.58 lakh high-risk villages and wards, congregate settings and vulnerable populations. The aim of this approach is to find people with TB before they seek care themselves, rather than waiting for them to arrive at a clinic.
The screening identified 48.64 lakh new TB cases, including 14.97 lakh people without symptoms, the ministry said. Detecting nearly 15 lakh asymptomatic cases is significant because people without symptoms might otherwise remain undiagnosed, delaying their treatment and potentially contributing to further transmission. The campaign also reported that 67,933 panchayats were declared TB-free in 2025, a marker of progress at the village level.
Technology in detection and treatment
The Health Ministry attributed India's mortality reduction to interventions under the National TB Elimination Programme (NTEP), including proactive case finding using AI-enabled X-rays, rapid diagnostics, prompt treatment initiation, differentiated TB care and nutritional support. Portable AI-enabled digital X-rays and rapid molecular diagnostic tests are being used to identify cases, particularly among high-risk populations, and the ministry said the expansion of these tools has strengthened the programme's ability to reach people across different geographical settings.
Artificial intelligence is also being used beyond the X-ray itself. According to the ministry, AI tools help identify disease hotspots and predict which patients are at greater risk of adverse treatment outcomes. The programme has introduced tools such as the Khushi AI chatbot and an Avatar Videobot, alongside the Ni-kshay digital platform, which supports patient tracking, treatment monitoring and programme management. Together, these tools are meant to keep patients connected to care from diagnosis through the end of treatment.
TB screening is also being integrated with the identification and management of other health conditions, including diabetes and undernutrition, to provide more comprehensive patient care. This matters because the WHO report links a large share of new TB cases to underlying risk factors: an estimated 9.6 lakh new cases were attributable to undernutrition, 9.2 lakh to diabetes, 7.3 lakh to alcohol use disorders, 6.9 lakh to smoking and 5.5 lakh to HIV infection. People with compromised immune systems, such as those living with HIV, undernutrition or diabetes, or people who use tobacco, have a higher risk of falling ill with TB.
Nutrition, community support and the 94% treatment success rate
Nutritional assistance remains a key component of India's TB treatment programme. Under the Ni-kshay Poshan Yojana, eligible patients receive financial assistance towards their nutritional requirements during treatment. The Ni-kshay Mitra initiative encourages individuals, institutions and organisations to provide nutritional and psychosocial support to people undergoing TB treatment. The ministry said these interventions, along with improved diagnostics, timely treatment initiation and patient follow-up, have contributed to better treatment outcomes.
Community participation has been a major part of the programme. Panchayati Raj institutions, urban local bodies, elected representatives, civil society organisations, private healthcare providers, corporate partners and community leaders have been involved in awareness, screening and patient support. The ministry described India's fight against TB as a nationwide people's movement, bringing together government institutions, healthcare professionals, communities and citizens.
Youth participation is being organised through JOSH Teams, which are being constituted at block and ward levels, led by designated Class-I officers and supported by five NCC cadets and five MY Bharat volunteers. The teams are expected to take part in awareness campaigns, community outreach and mobilisation activities. The government also said that India meets 96 per cent of its TB programme funding requirements through domestic resources, which the ministry presented as evidence of sustained national investment in TB elimination.
The global picture: India in context
Globally, tuberculosis remains the world's leading cause of death from a single infectious agent, according to the WHO report. An estimated 10.6 million people fell ill with TB worldwide in 2025, including 5.7 million men, 3.7 million women and 1.2 million children, and a total of 1.13 million people died from the disease in 2025. Global efforts to combat TB have saved an estimated 86 million lives since 2000, the report said.
India's share of the global burden remains large. The country accounted for about a quarter of people who developed TB worldwide in 2025, and the South-East Asia Region recorded the largest number of new TB cases at 35 per cent, followed by the Western Pacific Region at 27 per cent and the African Region at 25 per cent. Around 88 per cent of new TB cases occurred in 30 countries, with Indonesia, the Philippines, China, Pakistan, Nigeria, the Democratic Republic of the Congo and Bangladesh among the largest contributors after India.
Drug-resistant TB remains a serious concern worldwide. Multidrug-resistant TB (MDR-TB) remains a public health crisis and a health security threat, and only about two in five people with drug-resistant TB received treatment in 2025, according to the report. The WHO figures also highlight the financial burden of the disease: globally, about 50 per cent of people treated for TB and their households face total costs, including direct medical spending, non-medical spending and income losses, that are catastrophic, meaning greater than 20 per cent of total household income.
What remains unfinished
The report's positive headline figures sit alongside a continuing burden of disease. The detection of 48.64 lakh new TB cases through intensified screening underlines how widespread TB remains in India, even as deaths fall. Finding more cases is a sign that the detection system is working, but it is also a reminder that a large number of people are still falling ill, and each of them needs months of treatment, follow-up and support.
Tuberculosis is an infectious disease caused by bacteria that most often affects the lungs, and it spreads through the air when people with TB cough, sneeze or spit. The WHO notes that TB is preventable and curable, which makes the remaining deaths all the more significant: they represent cases where prevention, detection or treatment did not reach the person in time. The programme's stated focus remains on early detection, access to rapid diagnostics, timely treatment, preventive therapy, nutritional support and sustained community participation.
The government has said it will continue to build on the gains in the WHO report through intensified screening, expanded access to quality diagnostics, prompt and effective treatment, TB preventive treatment, nutritional assistance and deeper community engagement. The updated country profile expected from the WHO after its technical discussions with ICMR-NIRT will be the next check on whether the 38 per cent decline and the 94 per cent treatment success rate hold up as more evidence is assessed.
Editorial disclosure
This article was researched with AI assistance and reviewed by the publisher before publication. Report factual errors through our contact page.
Frequently asked questions
What did the WHO Global Tuberculosis Report 2026 say about India?
The report, released on 12 November 2026, records a 38 per cent reduction in India's estimated TB mortality since 2015, compared with a global decline of 35 per cent, and a 94 per cent treatment success rate among patients with drug-susceptible TB.
How much did India's TB mortality rate fall?
According to the report and the Union Health Ministry, India's estimated TB mortality rate fell from 28 deaths per lakh population in 2015 to 18 per lakh in 2025.
What is the TB Mukt Bharat Abhiyaan?
It is the government's intensified TB screening campaign. Between 7 December 2024 and 8 November 2026, it brought more than 25 crore people into screening, conducted over 11 crore chest X-rays and identified 48.64 lakh new TB cases, including 14.97 lakh asymptomatic cases.
What is drug-susceptible TB?
Drug-susceptible TB is tuberculosis that responds to standard medicines. The 94 per cent treatment success rate reported by the WHO applies to patients with this form of TB, not to drug-resistant TB.
How big is the global TB burden?
The WHO report estimates that 10.6 million people fell ill with TB worldwide in 2025 and 1.13 million died from it. India accounted for about a quarter of people who developed TB globally.